Uterine Atony Clinical Trial
Official title:
Novel Approach of Hayman Uterine Compression Sutures for Management of Severe Atonic Postpartum Hemorrhage: Three Vertical Sutures
NCT number | NCT04690153 |
Other study ID # | hayman |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | August 15, 2015 |
Est. completion date | December 15, 2020 |
Verified date | December 2020 |
Source | Kanuni Sultan Suleyman Training and Research Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Maternal deaths due to uterine atony bleeding are the leading causes of maternal death in our country and all over the world. In this respect, our clinic is among the clinics with the highest number of experience in our country and aims to reduce maternal deaths and mothers who will need intensive care due to bleeding with a hemorrhage stopping technique that will have a serious contribution to both our country and the world literature. Our primary goal, thanks to the bleeding-stopping technique, to reduce their deaths. Our secondary aim is, thanks to the bleeding-stopping technique we offer, To prevent and reduce the complications seen in mothers during the operative period.
Status | Completed |
Enrollment | 50 |
Est. completion date | December 15, 2020 |
Est. primary completion date | December 10, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - Postpartum bleeding after birth - Patients referred to our clinic from an external center due to postpartum bleeding - Patients who have given birth due to pregnancy older than 24 weeks and have atony bleeding Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
Turkey | Pinar Yalcin Bahat | Istanbul | I?stanbul |
Lead Sponsor | Collaborator |
---|---|
Pinar Yalcin bahat | Ismail Ozdemir |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reduce maternal deaths due to bleeding | Maternal death due to uterine atony is common all over the world, especially in developing countries. Thanks to the technique we apply, it is aimed to reduce bleeding and decrease maternal deaths. | 5 years | |
Secondary | to prevent and reduce complications seen in mothers in the post-operative period due to bleeding, | Some complications may occur due to excessive bleeding after uterine atony. These complications can be permanent or fatal. (for example, acute renal failure, disseminated intravascular coagulation disorder, etc., it is aimed to reduce these with the applied technique. | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT02910115 -
Cooling the Uterus in C-section After Dysfunctional Labor
|
N/A | |
Withdrawn |
NCT02410655 -
An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery
|
Phase 4 | |
Completed |
NCT00790062 -
Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT
|
Phase 4 | |
Recruiting |
NCT01579201 -
ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery
|
Phase 4 | |
Completed |
NCT03867383 -
Calcium Chloride for Prevention of Uterine Atony During Cesarean
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03584854 -
Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial
|
Phase 4 | |
Completed |
NCT02780245 -
Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section
|
Phase 4 | |
Completed |
NCT00785395 -
Up-Down Oxytocin Infusion
|
Phase 4 | |
Withdrawn |
NCT03303235 -
Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections
|
Early Phase 1 | |
Completed |
NCT02229513 -
Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage
|
N/A | |
Not yet recruiting |
NCT06192836 -
Placental Removal Method And Uterine Massage On Preventing Postpartum Hemorrhage
|
||
Recruiting |
NCT03413917 -
Exploration and Determination of Genomic Markers Predictive of Uterine Atony
|
||
Withdrawn |
NCT01252342 -
Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery?
|
Phase 4 | |
Completed |
NCT05027048 -
Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
|
Phase 3 | |
Completed |
NCT01630187 -
Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section
|
Phase 4 | |
Completed |
NCT01549223 -
Oxytocin And Uterotonic Agent Use For Cesarean Delivery
|
Phase 4 |